Brendan M. Weiss - Concepedia

Author

Brendan M. Weiss

Also Known As

Ahmadi, Tahamtan, Ashutosh D. Wechalekar, B M Weiss, B Weiss, B. M. Weiss, B. Weiss, B. Weiß, B.M. Weiss, BRENDAN M. WEISS, Brenda M Weiss

192

Publications

16.9K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Janssen (United States)Emory University Levine Cancer Institute City of Hope

About

Brendan M. Weiss is an author at University of Pennsylvania specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	8.2K
2	Health Sciences	8	8	4.9K
3	Public Health	4	4	319
4	Business	1	1	211
5	Allergy	1	1	158

Brendan M. Weiss

Publications

14.6K

Citations

H-Index

Page 1

	Year	Citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, The Lancet Oncology Hematological MalignancyMedicineHematologyDiagnosisPathology	2014	4.7K
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma Jakub Krejcik, Tineke Casneuf, Inger S. Nijhof, Blood	2016	890
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani, The Lancet Hematological MalignancyOncologyDaratumumab MonotherapyImmunologyClinical Trials	2016	842
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorAntigen-specific Antitumor Effects	2015	832
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, Journal of Clinical Investigation	2019	768
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, New England Journal of Medicine Cell TherapyImmunologyPathologyAutologous TransplantationCd4 T Cell Responses	2015	614
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, New England Journal of Medicine	2021	609
A monoclonal gammopathy precedes multiple myeloma in most patients Brendan M. Weiss, Jude Abadie, Pramvir S. Verma, Blood	2009	559
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma Ajai Chari, Attaya Suvannasankha, Joseph W. Fay, Blood	2017	438
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma Saad Z. Usmani, Brendan M. Weiss, Torben Plesner, Blood	2016	399

Page 1